Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Fingerpaint Adds Lead Creative to Villanova Office

VILLANOVA, PA – Fingerpaint (, a full-service marketing agency based in Saratoga Springs, New York, has added Brian Crooks to lead its creative team in the agency’s Villanova, Pennsylvania office. Crooks brings to Fingerpaint experience that spans a spectrum of industries, including automotive, fashion, insurance, healthcare, technology, nonprofit, publishing and finance, among others. Throughout his […]

Read More »

Intouch Solutions Promotes Greg Schutta to VP of Client Services

KANSAS CITY (June 04, 2015) — Intouch Solutions proudly announces the promotion of Greg Schutta to vice president, client services. A leading marketing agency serving the pharmaceutical industry, Intouch has seen rapid expansion over the past five years and actively promotes experienced leaders from within the 650-person firm. Schutta joined Intouch as a group account […]

Read More »

Reltio and ZS Join Forces on a Revolutionary Oncology Solution

ARTiS™ Oncology Powered by Reltio Selected by Leading Public Biopharmaceutical Company for Cancer Drug Launch Redwood Shores, CA – June 10, 2015 – Reltio, the enterprise data-driven applications and modern data management company and global sales and marketing firm, ZS, announced today that ZS is embedding Reltio Cloud in their ARTiS™ Oncology and Specialty Therapeutics […]

Read More »

Principal/Co-Founder Larry Wolheim Retires from Giant

SAN FRANCISCO, JUNE 8, 2015–Giant Creative/Strategy, LLC, the largest full-service independent healthcare communications agency on the West Coast, announced that Larry Wolheim, principal and co-founder, has retired. Wolheim’s career in the industry spanned more than four decades. Wolheim’s retirement comes after Steven Gold, principal, was named CEO.  During his 13 years at Giant, Wolheim led […]

Read More »

John Ruvane Joins NextWorks as SVP Business Development

New York, NY, June 8, 2015.  NextWorks, developer of the Content Capsule™ digital marketing platform, has named pharmaceutical and healthcare marketing veteran John Ruvane as Senior Vice President, Business Development. Ruvane will be based in New York.   “John brings extensive experience in healthcare and pharmaceutical marketing,” said Tim Bahr, NextWorks CEO. “His expertise and […]

Read More »

(e-)Conversations with my doctor

How ambient technologies will reshape the health care marketplace By Kim Bishop, VP of client services at Intouch Solutions Do you remember what consumer technology looked like 10 years ago? Here’s a quick refresher. Apple had just sold 200 million songs through iTunes, and would sell more than 20 million iPods in the following year. […]

Read More »

Sales and Marketing: Facts & Figures

While development of personalized medicines has grown since the human genome was first sequenced in 2001, biopharmaceutical sponsors face a number of hurdles that are impeding more rapid market uptake, according to a recently completed study by the Tufts Center for the Study of Drug Development. Fourteen years after the human genome was initially sequenced, […]

Read More »

End-of-life care

How to determine the right strategy for mature brands By Tim Arendt, Fahti Khosrow-Shahi, and Seb Morisot Tim Arendt is VP, Fahti Khosrow-Shahi is managing director, and Seb Morisot is engagement manager, Campbell Alliance. Based on current trends, soon 90 percent of products dispensed will be for a generic. As a result, companies are more […]

Read More »

DTC Special Feature: Direct to human

The impact of Viagra’s most recent DTC campaign has brand managers talking about the “humanity” of their communications.   It is sometimes easy to forget that the audience at the other end of pharmaceutical brands’ direct to consumer communications consists of ordinary humans. For all the new technologies and channels at hand today, brand managers […]

Read More »

Merck’s Quest To Revive The Market For Insomnia Drugs

In March, just one month after Merck introduced its new insomnia drug, Belsomra, physicians were writing 4,000 prescriptions a week for the new product—enough for CEO Kenneth Frazier to declare the launch a success during the company’s first-quarter earnings call. Excitement over the Belsomra is so high, in fact, that U.K.-based consulting firm GlobalData predicts […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

April 2019 Focus: Healthcare agency & network profiles, industry overview & awards, and more!


Ad Right Bottom